These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Use of captopril in arterial hypertension with a stable and malignant course]. Lordkipanidze NL Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432 [No Abstract] [Full Text] [Related]
23. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension. Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092 [TBL] [Abstract][Full Text] [Related]
24. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M; Richter WO; Schwandt P; Holzgreve H Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [TBL] [Abstract][Full Text] [Related]
25. [New options in the drug treatment of hypertension: claim and reality]. Unger T Dtsch Med Wochenschr; 2002 Nov; 127(45):2404-6. PubMed ID: 12422301 [No Abstract] [Full Text] [Related]
26. Managing hypertension in patients with chronic kidney disease. Zuber K; Gilmartin C; Davis J JAAPA; 2014 Sep; 27(9):37-46. PubMed ID: 25148442 [TBL] [Abstract][Full Text] [Related]
28. [Diuretics and beta blockers in the treatment of mild hypertension]. Vanhanen H; Strandberg T Duodecim; 1993; 109(4):273-5. PubMed ID: 7912181 [No Abstract] [Full Text] [Related]
29. [Changes in the renin-angiotensin system and the effectiveness of the treatment of hypertension with calcium antagonists, beta-adrenoblockers and diuretics]. Svishchenko EP Kardiologiia; 1992 Sep; 32(9-10):41-4. PubMed ID: 1363127 [TBL] [Abstract][Full Text] [Related]
30. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone. Helgeland A J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414 [TBL] [Abstract][Full Text] [Related]
31. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries]. Shabalin AV; Nikitin IuP Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043 [No Abstract] [Full Text] [Related]
32. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients. Paran E; Anson O; Neumann L Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675 [TBL] [Abstract][Full Text] [Related]
35. Hypertension: drug therapy options for older patients. Butler RN; August P; Ferdinand KC; Phillips RA; Roccella EJ Geriatrics; 1999 Jul; 54(7):27-8, 33-4, 37. PubMed ID: 10431597 [No Abstract] [Full Text] [Related]
36. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension. Bramlage P Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001 [TBL] [Abstract][Full Text] [Related]
37. Drug treatment of hypertension. Dahlöf B Neth J Med; 1993 Nov; 43 Suppl 1():S52-65. PubMed ID: 7904729 [No Abstract] [Full Text] [Related]
38. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group. Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675 [No Abstract] [Full Text] [Related]